Dragoi, A.M.;                     Radulescu, I.;                     Năsui, B.A.;                     Pop, A.L.;                     Varlas, V.N.;                     Trifu, S.    
        Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sci. 2020, 10, 840.
    https://doi.org/10.3390/brainsci10110840
    AMA Style
    
                                Dragoi AM,                                 Radulescu I,                                 Năsui BA,                                 Pop AL,                                 Varlas VN,                                 Trifu S.        
                Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sciences. 2020; 10(11):840.
        https://doi.org/10.3390/brainsci10110840
    
    Chicago/Turabian Style
    
                                Dragoi, Ana Miruna,                                 Ioana Radulescu,                                 Bogdana Adriana Năsui,                                 Anca Lucia Pop,                                 Valentin Nicolae Varlas,                                 and Simona Trifu.        
                2020. "Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19" Brain Sciences 10, no. 11: 840.
        https://doi.org/10.3390/brainsci10110840
    
    APA Style
    
                                Dragoi, A. M.,                                 Radulescu, I.,                                 Năsui, B. A.,                                 Pop, A. L.,                                 Varlas, V. N.,                                 & Trifu, S.        
        
        (2020). Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19. Brain Sciences, 10(11), 840.
        https://doi.org/10.3390/brainsci10110840